Smoking increases the risk of COVID-19 positivity, while Never-smoking reduces the risk
barasa, s.; Kiage-Mokaya, J.; Friedlander, M.; Cruz-Madrid, K.
Show abstract
IntroductionDoes smoking decrease the risk of testing positive for COVID-19 because the never-smokers (84%) prevalence is high and the current-smokers prevalence is low among COVID-19 positive patients? 1,2,3,4,5,6 We sought to determine whether never smoking increases the risk of COVID-19 positivity among the 50 to 69-year old patients because they are more likely to test positive for COVID-19.7 MethodWe conducted a retrospective chart review of COVID-19 Polymerase chain reaction, in-hospital tested [≥]18-year-old patients. A Poisson regression analysis stratified into never-smokers and history of smoking (current + former smokers) was conducted. Results277 COVID-19 negative and 117 COVID-19 positive patients charts with a never-smokers prevalence of 42.32% and 54% respectively were analyzed. The never-smokers prevalence was 54%, 20-39-years; 61 %, 40 -49-years; 41%, 50 - 69-years; and 43%, 70 - 100-years. The 40-49-year-old current and former smokers were more likely to test positive for COVID-19 [1.309 (1.047 - 1.635)], unlike the 40-49-year-old never-smokers [0.976 (0.890-1.071)] who had a lower risk. Regardless of their smoking status, males [1.084(1.021 - 1.151)] and the 50-69-year-old patients [1.082 (1.014 -1.154)] were more likely to test positive for COVID-19, while end stage renal disease [0.908(0.843-0.978)] and non-COVID-19 respiratory viral illness [0.907 (0.863 - 0.953)] patients had a lower risk of COVID-19 positivity. Heart failure [0.907 (0.830 - 0.991)], chronic obstructive pulmonary disease (COPD) [0.842 (0.745 - 0.952)] and Parkinsons disease [0.823 (0.708 - 0.957)] never-smokers were less likely to test positive for COVID-19. ConclusionThis is the first study to show that smoking increases the risk of COVID-19 positivity among the 40-49-year-old patients, while not smoking reduces the risk of COVID-19 positivity among the heart failure, COPD and Parkinsons disease patients. This study emphasizes that COVID-19 positivity risk is not reduced by smoking and not increased by not smoking.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Effect of smoking on drug-resistant tuberculosis treatment outcomes and potential mechanistic pathways: A multicountry cohort study 90%
- Two-way remote monitoring allows effective and realistic provision of home-NIV to COPD patients with persistent hypercapnia 90%
- Vitamin D Status: A U-shaped relationship for SARS-CoV-2 seropositivity in UK healthcare workers 90%
Similar papers in this journal
- E-cigarette use and Respiratory Symptoms in Residents of the United States: A BRFSS Report 94%
- Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis 93%
- Obesity and Smoking as Risk Factors for Invasive Mechanical Ventilation in COVID-19: a Retrospective, Observational Cohort Study 93%
Similar papers in this journal
- COPD in the time of COVID-19: An analysis of acute exacerbations and reported behavioural changes in patients with COPD 92%
- Quit attempts and tobacco abstinence in primary care patients: long-term follow-up of a pragmatic, two-arm cluster randomised controlled trial on brief stop-smoking advice (ABC versus 5As method) 90%
- Symptoms persisting after hospitalization for COVID-19: 12 months interim results of the COFLOW study 90%
Similar papers in this journal
- Changes in Cardiovascular Disease Risk, Lung Function, and Other Clinical Health Outcomes When People Who Smoke Use E-cigarettes to Reduce Cigarette Smoking: An Exploratory Analysis from a Randomized Placebo-Controlled Trial 94%
- Smoking in social housing among adults in England, 2015-2020: a nationally representative survey 92%
- E-cigarette use and combustible tobacco cigarette smoking uptake among non-smokers, including relapse in former smokers: umbrella review, systematic review and meta-analysis 92%
Similar papers in this journal
- Review of evidence regarding attributes and behaviours of smokers as smoking prevalence falls, including evidence relevant to the 'hardening hypothesis' 94%
- Associations between e-cigarette use and e-cigarette flavors with cigarette smoking quit attempts and quit success: Evidence from a US large, nationally representative 2018-2019 survey 93%
- Smoking is Associated with COVID-19 Progression: A Meta-Analysis 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.